BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 29031613)

  • 1. Pathogenic mutations of the human mitochondrial citrate carrier SLC25A1 lead to impaired citrate export required for lipid, dolichol, ubiquinone and sterol synthesis.
    Majd H; King MS; Smith AC; Kunji ERS
    Biochim Biophys Acta Bioenerg; 2018 Jan; 1859(1):1-7. PubMed ID: 29031613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An overview of combined D-2- and L-2-hydroxyglutaric aciduria: functional analysis of CIC variants.
    Pop A; Williams M; Struys EA; Monné M; Jansen EEW; De Grassi A; Kanhai WA; Scarcia P; Ojeda MRF; Porcelli V; van Dooren SJM; Lennertz P; Nota B; Abdenur JE; Coman D; Das AM; El-Gharbawy A; Nuoffer JM; Polic B; Santer R; Weinhold N; Zuccarelli B; Palmieri F; Palmieri L; Salomons GS
    J Inherit Metab Dis; 2018 Mar; 41(2):169-180. PubMed ID: 29238895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined D2-/L2-hydroxyglutaric aciduria (SLC25A1 deficiency): clinical course and effects of citrate treatment.
    Mühlhausen C; Salomons GS; Lukacs Z; Struys EA; van der Knaap MS; Ullrich K; Santer R
    J Inherit Metab Dis; 2014 Sep; 37(5):775-81. PubMed ID: 24687295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deficiency in SLC25A1, encoding the mitochondrial citrate carrier, causes combined D-2- and L-2-hydroxyglutaric aciduria.
    Nota B; Struys EA; Pop A; Jansen EE; Fernandez Ojeda MR; Kanhai WA; Kranendijk M; van Dooren SJ; Bevova MR; Sistermans EA; Nieuwint AW; Barth M; Ben-Omran T; Hoffmann GF; de Lonlay P; McDonald MT; Meberg A; Muntau AC; Nuoffer JM; Parini R; Read MH; Renneberg A; Santer R; Strahleck T; van Schaftingen E; van der Knaap MS; Jakobs C; Salomons GS
    Am J Hum Genet; 2013 Apr; 92(4):627-31. PubMed ID: 23561848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel homozygous SLC25A1 mutation with impaired mitochondrial complex V: Possible phenotypic expansion.
    Cohen I; Staretz-Chacham O; Wormser O; Perez Y; Saada A; Kadir R; Birk OS
    Am J Med Genet A; 2018 Feb; 176(2):330-336. PubMed ID: 29226520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mitochondrial citrate carrier in Yarrowia lipolytica: Its identification, characterization and functional significance for the production of citric acid.
    Yuzbasheva EY; Agrimi G; Yuzbashev TV; Scarcia P; Vinogradova EB; Palmieri L; Shutov AV; Kosikhina IM; Palmieri F; Sineoky SP
    Metab Eng; 2019 Jul; 54():264-274. PubMed ID: 31071446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical characterization of human D-2-hydroxyglutarate dehydrogenase and two disease related variants reveals the molecular cause of D-2-hydroxyglutaric aciduria.
    Toplak M; Brunner J; Schmidt J; Macheroux P
    Biochim Biophys Acta Proteins Proteom; 2019 Nov; 1867(11):140255. PubMed ID: 31349060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial Citrate Transporters CtpA and YhmA Are Required for Extracellular Citric Acid Accumulation and Contribute to Cytosolic Acetyl Coenzyme A Generation in Aspergillus luchuensis mut.
    Kadooka C; Izumitsu K; Onoue M; Okutsu K; Yoshizaki Y; Takamine K; Goto M; Tamaki H; Futagami T
    Appl Environ Microbiol; 2019 Apr; 85(8):. PubMed ID: 30737343
    [No Abstract]   [Full Text] [Related]  

  • 9. A conserved role for the mitochondrial citrate transporter Sea/SLC25A1 in the maintenance of chromosome integrity.
    Morciano P; Carrisi C; Capobianco L; Mannini L; Burgio G; Cestra G; De Benedetto GE; Corona DF; Musio A; Cenci G
    Hum Mol Genet; 2009 Nov; 18(21):4180-8. PubMed ID: 19654186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case report of an intermediate phenotype between congenital myasthenic syndrome and D-2- and L-2-hydroxyglutaric aciduria due to novel SLC25A1 variants.
    Li W; Zhang M; Zhang L; Shi Y; Zhao L; Wu B; Li X; Zhou S
    BMC Neurol; 2020 Jul; 20(1):278. PubMed ID: 32660532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agenesis of corpus callosum and optic nerve hypoplasia due to mutations in SLC25A1 encoding the mitochondrial citrate transporter.
    Edvardson S; Porcelli V; Jalas C; Soiferman D; Kellner Y; Shaag A; Korman SH; Pierri CL; Scarcia P; Fraenkel ND; Segel R; Schechter A; Frumkin A; Pines O; Saada A; Palmieri L; Elpeleg O
    J Med Genet; 2013 Apr; 50(4):240-5. PubMed ID: 23393310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Insights into Behçet's Syndrome Metabolic Reprogramming: Citrate Pathway Dysregulation.
    Santarsiero A; Leccese P; Convertini P; Padula A; Abriola P; D'Angelo S; Bisaccia F; Infantino V
    Mediators Inflamm; 2018; 2018():1419352. PubMed ID: 30050389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A key role of the mitochondrial citrate carrier (SLC25A1) in TNFα- and IFNγ-triggered inflammation.
    Infantino V; Iacobazzi V; Menga A; Avantaggiati ML; Palmieri F
    Biochim Biophys Acta; 2014 Nov; 1839(11):1217-1225. PubMed ID: 25072865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mitochondrial citrate carrier, SLC25A1, drives stemness and therapy resistance in non-small cell lung cancer.
    Fernandez HR; Gadre SM; Tan M; Graham GT; Mosaoa R; Ongkeko MS; Kim KA; Riggins RB; Parasido E; Petrini I; Pacini S; Cheema A; Varghese R; Ressom HW; Zhang Y; Albanese C; Üren A; Paige M; Giaccone G; Avantaggiati ML
    Cell Death Differ; 2018 Jul; 25(7):1239-1258. PubMed ID: 29651165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Mitochondrial Citrate Carrier SLC25A1/CIC and the Fundamental Role of Citrate in Cancer, Inflammation and Beyond.
    Mosaoa R; Kasprzyk-Pawelec A; Fernandez HR; Avantaggiati ML
    Biomolecules; 2021 Jan; 11(2):. PubMed ID: 33499062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Manifestation of recessive combined D-2-, L-2-hydroxyglutaric aciduria in combination with 22q11.2 deletion syndrome.
    Eguchi M; Ozaki E; Yamauchi T; Ohta M; Higaki T; Masuda K; Imoto I; Ishii E; Eguchi-Ishimae M
    Am J Med Genet A; 2018 Feb; 176(2):351-358. PubMed ID: 29265763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative metabolic flux analysis reveals an unconventional pathway of fatty acid synthesis in cancer cells deficient for the mitochondrial citrate transport protein.
    Jiang L; Boufersaoui A; Yang C; Ko B; Rakheja D; Guevara G; Hu Z; DeBerardinis RJ
    Metab Eng; 2017 Sep; 43(Pt B):198-207. PubMed ID: 27856334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A
    Li H; Hurlburt AJ; Tennessen JM
    Dis Model Mech; 2018 Sep; 11(9):. PubMed ID: 30108060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The yeast mitochondrial citrate transport protein: molecular determinants of its substrate specificity.
    Aluvila S; Kotaria R; Sun J; Mayor JA; Walters DE; Harrison DHT; Kaplan RS
    J Biol Chem; 2010 Aug; 285(35):27314-27326. PubMed ID: 20551333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial Citrate Transporter-dependent Metabolic Signature in the 22q11.2 Deletion Syndrome.
    Napoli E; Tassone F; Wong S; Angkustsiri K; Simon TJ; Song G; Giulivi C
    J Biol Chem; 2015 Sep; 290(38):23240-53. PubMed ID: 26221035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.